PYPD
PolyPid Ltd.stockNASDAQ
At CloseNov 17, 2026 3:59:56 PM EST
6.50USD+5.691%(+0.35)760,313
Pre-marketNov 17, 2026 9:26:30 AM EST
6.20USD+0.813%(+0.05)
After-hoursNov 17, 2026 4:27:30 PM EST
6.65USD+2.308%(+0.15)
PYPD Reddit Mentions by subreddit
Loading…
PYPD Mentions × sentiment
Loading…
PYPD Specific Mentions latest comments & posts
PYPD
sentiment 0.000
PYPD won’t have the upside that SLS had but it’s a good bet for approval imo
sentiment 0.840
I’m a beginner, and I’ve recently become very interested in small-cap biotech stocks, especially companies with upcoming catalysts that could trigger significant price movements.
I recently missed the massive run-up in SELLAS Life Sciences (SLS), and I’m trying to learn how to identify similar opportunities before they take off, rather than chasing stocks after they’ve already exploded.
After doing some research, I’ve narrowed my watchlist down to these 11 companies:
● NGEN – NervGen Pharma
● GANX – Gain Therapeutics
● MAIA – MAIA Biotechnology
● CATX – Perspective Therapeutics
● DRTS – Alpha Tau Medical
● IBRX – ImmunityBio
● OTLK – Outlook Therapeutics
● SMMT – Summit Therapeutics
● PYPD – PolyPid
● SVRA – Savara
● CAPR – Capricor Therapeutics
I’d really appreciate your thoughts on a few questions:
1. Which of these stocks would you actually consider buying right now, and why?
2. Which have the strongest upcoming catalysts?
3. Which stocks would you avoid entirely?
sentiment 0.911
I dunno why but my spider sense smells something fishy with this tech. When it's too good to be true and market hasn't reacted yet... I'll pass, but thanks for your answer. I'm considering more IBRX and PYPD.
sentiment 0.908
IBRX and PYPD for me.
sentiment 0.000
$PYPD A $1.65 Billion Buyout Deal Puts a Spotlight on PolyPid Ahead of Its FDA Decision
sentiment -0.361